이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Lifecare 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Joacim Holter

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.8yrs
CEO 소유권	0.2%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	3.7yrs

최근 관리 업데이트

Recent updates

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Apr 30

CEO

Joacim Holter

3.8yrs

테뉴어

Mr. Joacim Holter serves as Head of Investor Relation at Lifecare AS. He has been the Chief Executive Officer at Lifecare AS since September 06, 2020 and had been a Director since 2011. He was the Chairman...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Bo Petersson	Independent Director	3.7yrs	데이터 없음	데이터 없음
Hans Hekland	Independent Director	3.2yrs	데이터 없음	0.12% NOK 406.0k
Lutz Heinemann	Member of Scientific Advisory Board & Independent Director	3.7yrs	데이터 없음	데이터 없음
David Klonoff	Chairman of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Morten Krohnstad	Independent Chairman of the Board	3.7yrs	데이터 없음	데이터 없음
Kåre Birkeland	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Michael Huth	Member of Scientific Advisory Board	4.5yrs	데이터 없음	데이터 없음
Trine Teigland	Independent Director	4.1yrs	데이터 없음	데이터 없음
Tony James	Member of Scientific Advisory Board	less than a year	데이터 없음	데이터 없음

3.7yrs

평균 재임 기간

경험이 풍부한 이사회: LIFE 의 이사회는 경험(평균 재직 기간 3.6 년)으로 간주됩니다.

Lifecare 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

No independent directors

Chief Executive Officer recently bought kr75k worth of stock

No independent directors

Recent updates

New major risk - Shareholder dilution

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 90 million.

Lifecare AS Files Application for a New Patent

Lifecare AS Announces Successful Pilot Production

Lifecare AS has filed a Follow-on Equity Offering in the amount of NOK 90 million.

Full year 2023 earnings released: kr0.29 loss per share (vs kr0.17 loss in FY 2022)

Full year 2023 earnings released: kr0.27 loss per share (vs kr0.15 loss in FY 2022)

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

New minor risk - Shareholder dilution

Lifecare AS Announces the Norwegian Food Safety Authority Receives Approval to Start LFC-SEN-002

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 42.5 million.

New major risk - Financial position

Lifecare AS to Report Q1, 2023 Results on May 10, 2023

No independent directors

Lifecare AS Announces Interim Data Analysis of the First In-Human Study

Lifecare as Initiates Clinical Studies of the Smallest Glucose Sensor in the Worldr People Diagnosed with Diabeabetes

Chief Executive Officer recently bought kr75k worth of stock

No independent directors

Lifecare AS (OB:LIFE) signed a term sheet agreement to acquire PFÜTZNER Science & Health Institute GmbH for €1.18 million.

Lifecare AS (OB:LIFE) acquired Cantimed Ug (Haftungsbeschrsnkt) from NanoScale Systems Gmbh for €0.65 million.

Chairman of the Board Christian Hysing-Dahl has left the company

We're Interested To See How Lifecare (OB:LIFE) Uses Its Cash Hoard To Grow

Lifecare AS to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day high: kr6.40

New 90-day low: kr3.62

Lifecare AS Announces Board Appointments

New 90-day low: kr4.00

Lifecare Receives EUR 3.9 Million from the EU Commission for Development of Bionic Invisible Pancreas to Forgetdiabetes

New 90-day high: kr7.00

Chief Scientific Officer recently sold kr270k worth of stock

Lifecare Appoints Joacim Holter as CEO

CEO

테뉴어

이사회 구성원

평균 재임 기간